A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Conditions
- Cutaneous Squamous Cell Carcinoma
- SCC - Squamous Cell Carcinoma
- Basal Cell Carcinoma
- BCC
- BCC - Basal Cell Carcinoma
- Melanoma
- Merkel Cell Carcinoma
- Sebaceous Carcinoma
- Extramammary Paget Disease
- Kaposi Sarcoma
- Head and Neck Squamous Cell Carcinoma
- HNSCC
- Adnexal Carcinoma
- Angiosarcoma
- Cutaneous Neoplasm
- Advanced Cancer
- Metastatic Cancer
- Refractory Cancer
- Solid Tumor
Interventions
- BIOLOGICAL: MQ719
- DRUG: Pembrolizumab
Sponsor
Memorial Sloan Kettering Cancer Center